Novasys Secures $50 Million in Series D Financing
Posted on May 15, 2008
Filed Under Women Health
Novasys Medical, the developer of Renessa, a non-surgical treatment for female stress urinary incontinence (SUI), secured $45 million in Series D preferred stock financing.
The round was led by Versant Ventures, with ThreeArch Partners and Skyline Ventures also participating as new investors.
Money will be used to further development and commercialization efforts of Renessa.
Comments
Leave a Reply
You must be logged in to post a comment.